Profits recover at Alibaba Health but prognosis unclear
The digital pharmacy and healthcare provider returned to profit in the last fiscal year but is still struggling to limit its reliance on drug sales Key Takeaways: Alibaba Health delivered…
0241.HK
Recent Articles
RELATED ARTICLES
- Margins ring alarm bells as 160 Health readies IPO
-
Ping An Health pins recovery hopes on new leadership
1833.HK
-
IFlytek hives off health unit to fund AI medical drive
002230.SHE
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
Alibaba International posts strong revenue growth, narrowing losses
BABA.US 9988.HK
-
Slowing revenue growth hurts online drug platform YSB
9885.HK
-
Everest reaches new heights on growing drug sales
1952.HK
Discover hidden China stock gems in our weekly newsletter